Estefanía Burgos‐Morón

3.4k total citations · 2 hit papers
34 papers, 2.3k citations indexed

About

Estefanía Burgos‐Morón is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Estefanía Burgos‐Morón has authored 34 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Toxicology. Recurrent topics in Estefanía Burgos‐Morón's work include Bioactive Compounds and Antitumor Agents (7 papers), Cancer therapeutics and mechanisms (7 papers) and DNA Repair Mechanisms (6 papers). Estefanía Burgos‐Morón is often cited by papers focused on Bioactive Compounds and Antitumor Agents (7 papers), Cancer therapeutics and mechanisms (7 papers) and DNA Repair Mechanisms (6 papers). Estefanía Burgos‐Morón collaborates with scholars based in Spain, Sweden and United Kingdom. Estefanía Burgos‐Morón's co-authors include Miguel López‐Lázaro, José Manuel Calderón‐Montaño, Concepción Pérez‐Guerrero, Manuel Luís Orta, Santiago Mateos, Sandra López‐Domènech, C Salom, A Marañón, Ana Jover and Zaida Abad‐Jiménez and has published in prestigious journals such as Nucleic Acids Research, Journal of Agricultural and Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Estefanía Burgos‐Morón

33 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Review on the Dietary Flavonoid Kaempferol

2011 1.1k citations José Manuel Calderón‐Montaño, Estefanía Burgos‐Morón et al. Mini-Reviews in Medicinal Chemistry profile →
Relationship between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues

2019 412 citations Estefanía Burgos‐Morón et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Estefanía Burgos‐Morón Spain	17	1.0k	399	351	250	249	34	2.3k
José Manuel Calderón‐Montaño Spain	20	1.1k 1.1×	389 1.0×	328 0.9×	244 1.0×	264 1.1×	50	2.2k
Jeremy J. Johnson United States	26	1.1k 1.1×	480 1.2×	431 1.2×	299 1.2×	151 0.6×	75	2.6k
Noriyuki Miyoshi Japan	31	1.5k 1.4×	352 0.9×	479 1.4×	182 0.7×	238 1.0×	125	3.0k
Carmela Spagnuolo Italy	24	1.4k 1.3×	418 1.0×	636 1.8×	261 1.0×	287 1.2×	48	3.2k
Mariam Abotaleb Qatar	9	788 0.8×	334 0.8×	437 1.2×	180 0.7×	161 0.6×	10	1.9k
Iva Boušová Czechia	20	888 0.9×	511 1.3×	648 1.8×	345 1.4×	263 1.1×	50	2.4k
Cristóvão F. Lima Portugal	24	878 0.8×	421 1.1×	462 1.3×	391 1.6×	194 0.8×	35	2.1k
Mohd Rais Mustafa Malaysia	33	982 0.9×	471 1.2×	315 0.9×	193 0.8×	252 1.0×	93	3.1k
Violetta Krajka‐Kuźniak Poland	25	1.2k 1.2×	297 0.7×	337 1.0×	246 1.0×	228 0.9×	97	2.3k
Hideo Satsu Japan	29	1.0k 1.0×	244 0.6×	388 1.1×	241 1.0×	122 0.5×	90	2.9k

Countries citing papers authored by Estefanía Burgos‐Morón

Since Specialization

Citations

This map shows the geographic impact of Estefanía Burgos‐Morón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estefanía Burgos‐Morón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estefanía Burgos‐Morón more than expected).

Fields of papers citing papers by Estefanía Burgos‐Morón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estefanía Burgos‐Morón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estefanía Burgos‐Morón. The network helps show where Estefanía Burgos‐Morón may publish in the future.

Co-authorship network of co-authors of Estefanía Burgos‐Morón

This figure shows the co-authorship network connecting the top 25 collaborators of Estefanía Burgos‐Morón. A scholar is included among the top collaborators of Estefanía Burgos‐Morón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estefanía Burgos‐Morón. Estefanía Burgos‐Morón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calderón‐Montaño, José Manuel, et al.. (2024). A Diet Lacking Selenium, but Not Zinc, Copper or Manganese, Induces Anticancer Activity in Mice with Metastatic Cancers. Nutrients. 16(14). 2249–2249.

Calderón‐Montaño, José Manuel, et al.. (2023). Artificial Diets with Selective Restriction of Amino Acids and Very Low Levels of Lipids Induce Anticancer Activity in Mice with Metastatic Triple-Negative Breast Cancer. Cancers. 15(5). 1540–1540. 8 indexed citations

Calderón‐Montaño, José Manuel, et al.. (2023). Artificial Diets with Altered Levels of Sulfur Amino Acids Induce Anticancer Activity in Mice with Metastatic Colon Cancer, Ovarian Cancer and Renal Cell Carcinoma. International Journal of Molecular Sciences. 24(5). 4587–4587. 2 indexed citations

Burgos‐Morón, Estefanía, Sarah Mazzotta, José Manuel Calderón‐Montaño, et al.. (2023). Repurposing Study of 4-Acyl-1-phenylaminocarbonyl-2-substituted-piperazine Derivatives as Potential Anticancer Agents—In Vitro Evaluation against Breast Cancer Cells. International Journal of Molecular Sciences. 24(23). 17041–17041. 2 indexed citations

Calderón‐Montaño, José Manuel, et al.. (2022). Artificial Diets Based on Selective Amino Acid Restriction versus Capecitabine in Mice with Metastatic Colon Cancer. Nutrients. 14(16). 3378–3378. 8 indexed citations

Calderón‐Montaño, José Manuel, et al.. (2022). Manipulation of Amino Acid Levels with Artificial Diets Induces a Marked Anticancer Activity in Mice with Renal Cell Carcinoma. International Journal of Molecular Sciences. 23(24). 16132–16132. 9 indexed citations

Calderón‐Montaño, José Manuel, Estefanía Burgos‐Morón, Miguel López‐Lázaro, et al.. (2021). Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity. Journal of Medicinal Chemistry. 64(14). 10350–10370. 18 indexed citations

Burgos‐Morón, Estefanía, Nuria Pastor, Manuel Luís Orta, et al.. (2021). In Vitro Anticancer Activity and Mechanism of Action of an Aziridinyl Galactopyranoside. Biomedicines. 10(1). 41–41. 5 indexed citations

Calderón‐Montaño, José Manuel, et al.. (2021). Screening for Selective Anticancer Activity of 65 Extracts of Plants Collected in Western Andalusia, Spain. Plants. 10(10). 2193–2193. 38 indexed citations

10.

Burgos‐Morón, Estefanía, Nuria Pastor, Manuel Luís Orta, et al.. (2018). Selective cytotoxic activity and DNA damage by an epoxyalkyl galactopyranoside. Drug Development Research. 79(8). 426–436. 2 indexed citations

11.

Calderón‐Montaño, José Manuel, et al.. (2018). A 30-s exposure to ethanol 20% is cytotoxic to human keratinocytes: possible mechanistic link between alcohol-containing mouthwashes and oral cancer. Clinical Oral Investigations. 22(8). 2943–2946. 18 indexed citations

12.

Orta, Manuel Luís, Nuria Pastor, Estefanía Burgos‐Morón, et al.. (2017). Zebularine induces replication-dependent double-strand breaks which are preferentially repaired by homologous recombination. DNA repair. 57. 116–124. 15 indexed citations

13.

Burgos‐Morón, Estefanía, et al.. (2016). Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid. Toxins. 8(7). 211–211. 5 indexed citations

14.

Orta, Manuel Luís, Andreas Höglund, José Manuel Calderón‐Montaño, et al.. (2014). The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions. Nucleic Acids Research. 42(14). 9108–9120. 71 indexed citations

15.

Calderón‐Montaño, José Manuel, Estefanía Burgos‐Morón, Manuel Luís Orta, & Miguel López‐Lázaro. (2014). Effect of DNA Repair Deficiencies on the Cytotoxicity of Drugs Used in Cancer Therapy - A Review. Current Medicinal Chemistry. 21(30). 3419–3454. 19 indexed citations

16.

Calderón‐Montaño, José Manuel, Estefanía Burgos‐Morón, Manuel Luís Orta, Santiago Mateos, & Miguel López‐Lázaro. (2013). A Hydroalcoholic Extract from the Leaves of Nerium oleander Inhibits Glycolysis and Induces Selective Killing of Lung Cancer Cells. Planta Medica. 79(12). 1017–1023. 40 indexed citations

17.

Orta, Manuel Luís, José Manuel Calderón‐Montaño, Inmaculada Domı́nguez, et al.. (2013). 5-Aza-2′-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair. Nucleic Acids Research. 41(11). 5827–5836. 53 indexed citations

18.

Martı́n-Cordero, Carmen, Antonio J. León‐González, José Manuel Calderón‐Montaño, Estefanía Burgos‐Morón, & Miguel López‐Lázaro. (2012). Pro-Oxidant Natural Products as Anticancer Agents. Current Drug Targets. 13(8). 1006–1028. 143 indexed citations

19.

Calderón‐Montaño, José Manuel, Estefanía Burgos‐Morón, Manuel Luís Orta, et al.. (2012). Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death. Pharmacological Reports. 64(6). 1515–1525. 8 indexed citations

20.

Calderón‐Montaño, José Manuel, Estefanía Burgos‐Morón, Concepción Pérez‐Guerrero, & Miguel López‐Lázaro. (2011). A Review on the Dietary Flavonoid Kaempferol. Mini-Reviews in Medicinal Chemistry. 11(4). 298–344. 1071 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact